Twists and turns across the US stock market this year from tariff threats to DeepSeek’s AI spook have done little to shake ...

Inflation expectations are rising, driven by tariff concerns and impacting consumer sentiment. Read more here.

Nick Scali reported its 1H25 results, with a mixed bag of takeaways Let's dive in. Major US benchmarks finished mixed, with ...

At the more established end of the market, US policy moves are muddying ... Dr Storey said he also favoured Neuren Pharmaceuticals, with the share price having come under pressure recently ...

It’s shaping up as a big year for late-stage Australian-listed drug developers, with analysts tipping potentially hefty share price rises for companies including Telix Pharmaceuticals, Clarity ...

Investing can seem intimidating: What if you make a bad choice and lose money? or what about a lack of access to quality investing advice? At the end of the day, however, that fear can be holding ...

NEW DELHI: The Nifty Bank index traded around 10:55AM(IST)on Thursday in an upbeat market. IndusInd Bank Ltd.(up 1.38 per cent), IDFC First Bank Ltd.(up 0.91 per cent), Federal Bank Ltd.(up 0.69 per ...

The S&P/ASX 200 Index (ASX: XJO) ended the week with a significant gain of 1.1%, settling at 6,977.1 points, propelled by the impressive performance of four ASX shares: Block Inc, ... ByInvesting.com ...

Historical Data is currently not available. Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.

Neuren Pharmaceuticals' (ASX:NEU) stock is up by a considerable 13% over the past week. Given that the market rewards strong financials in the long-term, we wonder if that is the case in this ...

Neuren Pharmaceuticals' (ASX:NEU) stock is up by a considerable 13% over the past week. Given that the market rewards strong financials in the long-term, we wonder if that is the case in this instance ...